title: Liver transplantation in Eastern Europe.
abstract: The aim of this report is to evaluate the development of liver transplantation in eastern Europe until mid-1998. Representatives of gastroenterological and hepatological societies of the respective countries answered a questionnaire about the most descriptive items of the issue of liver transplantation. The Baltic countries, together with 6 southern Balkan countries, Moldovia, and Belarus, have not developed a program of liver transplantation. In Ukraine, 7 transplantations were performed, with 3 early deaths. In Russia, 31 liver transplantations were performed, with 8 of the last 12 patients surviving short term. In Slovenia, 1 of 2 patients, and in Yugoslavia, 8 of 9 patients survived. In Croatia and Slovakia, 2 patients each died immediately after surgery. The number of liver transplantations is increasing in both Hungary and Poland. In Hungary, 63 transplantations were performed, with a 1-year survival rate reaching 85%; in Poland, 55 adults and 29 children underwent transplantation, with an actuarial 1-year survival rate of 70%. In former East Germany, 4 centers developed their programs since 1992. A total of 196 transplantations were performed, with 1-year survival rates varying from 80% to 89%. The total spectrum of indications for transplantation was standard, with a greater proportion of hepatocellular cancer compared with Eurotransplant statistics. In the Czech Republic, the first liver transplantation was performed in 1983, but it was not until 1994 that the number of procedures increased steeply. Until mid-1998, a total of 182 transplantations were performed. At the Prague Institute for Clinical and Experimental Medicine, we performed 94 transplantations, with a 1-year patient survival rate of 90.6%. There has been rapid development over the last 3 years in the 3 countries of Central Europe. The progress is influenced by the sweeping political and economic changes.
authors.affiliation: Institute for Clinical and Experimental Medicine, Prague, Czech Republic. julius.spicak@medicon.cz
authors.forename: J
authors.initials: J
authors.lastname: Spicák
authors.forename: S
authors.initials: S
authors.lastname: Vítko
authors.forename: M
authors.initials: M
authors.lastname: Ryska
authors.forename: P
authors.initials: P
authors.lastname: Trunecka
authors.forename: F
authors.initials: F
authors.lastname: Belina
authors.forename: M
authors.initials: M
authors.lastname: Krawczyk
authors.forename: F
authors.initials: F
authors.lastname: Perner
authors.forename: P
authors.initials: P
authors.lastname: Taimr
authors.forename: J
authors.initials: J
authors.lastname: Sperl
authors.forename: H
authors.initials: H
authors.lastname: Hrncárková
authors.forename: J
authors.initials: J
authors.lastname: Peregrín
authors.forename: H
authors.initials: H
authors.lastname: Filipová
authors.forename: K
authors.initials: K
authors.lastname: Filip
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000601:surgery; D002648:Child; D005061:Europe, Eastern; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery; D016031:Liver Transplantation / Q000706:statistics & numerical data / Q000639:trends*; D016019:Survival Analysis